IKT-203

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameIKT-203
Drug Alias Nameoncolytic vaccinia virus therapy expressing ADA modulator (Icell Kealex Therapeutics)ADA-VVIKT-203
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionAdenosine deaminase modulatorsImmunostimulants
TargetsAdenosine deaminase
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIcell Kealex Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIcell Kealex Therapeutics
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A